Skip to content
Search

Latest Stories

Increase protected learning time for NHS pharmacists – GHP launches national campaign

GHP calls for 10% mandated protected learning time for NHS pharmacists in new campaign
Many pharmacists end up doing ‘unpaid work’ to catch up with the required training (gettyimages)

Many pharmacists end up doing ‘unpaid work’ to catch up with the required training or completing self-learning in their own time.

The Guild of Healthcare Pharmacists (GHP) has launched a national campaign advocating for pharmacists working in the NHS to have a minimum of 10% of their contracted hours protected for supporting professional activities (SPA).

In a statement published on 7 February 2025, the GHP emphasised that this protected time “should be recognized by employers and embedded in job plans.”


The organisation highlighted the existing inconsistency across the UK regarding the amount of SPA time allocated to pharmacists and stressed the need for a consistent amount of development to “allow pharmacists to be able to be safe practitioners, to meet the demands of service development, and to be able to safely mentor and supervise more junior colleagues.”

The GHP raised concerns that many pharmacists end up doing “unpaid work” to catch up with the required training or completing self-learning in their own time.

“This pressure is unfair and unsustainable, potentially contributing to burnout and in combination with all the other pressures, leads to pharmacists leaving the NHS,” it stated.

The GHP asserted that a minimum of 10% of contracted hours for SPA is “a strongly justifiable argument.”

“This is to reflect the increase in professional responsibilities such as supervising junior colleagues with their prescribing, supporting undergraduate students, postgraduate education requirements, portfolio development, professional credentialing, and much more,” it explained.

The organisation stressed that it is within the scope of trusts, health boards and employers to grant this time to pharmacists, citing similar provisions in other professions.

Rob Connah, president of the GHP, underscored the urgency of implementing mandated protected learning time (PLT), particularly with the introduction of the General Pharmaceutical Council’s ‘Standards for the Initial Education and Training of Pharmacists’ in 2021.

With the new standards, all newly registered pharmacists would be able to prescribe independently from 2026.

Connah told The Pharmaceutical Journal: “There is a drastic increase of experiential learning, which places an emphasis on practice supervisors, and from 2025–2026, this will increase again to include a responsibility for developing safe prescribers at the point of registration.

“This increase in responsibility is a national expectation with little additional resource seen for individual pharmacists to accommodate.

“As services develop and become increasingly reliant upon specialist pharmacist skills and knowledge, the need for postgraduate qualifications has similarly increased. Services are limited by poor recruitment, retention and staff burnout.”

Claire Anderson, president of the Royal Pharmaceutical Society (RPS), echoed these concerns, calling on governments, NHS bodies, and employers to ensure regular, funded PLT and the infrastructure needed to support it to enable continuous professional development from foundation pharmacists to consultant level across Great Britain.

“We believe it is essential that learning time is considered in any future workforce plans,” she said.

Anderson also noted that PLT was a key topic at their 2024 workforce wellbeing roundtable with Pharmacist Support and will remain central to discussions with stakeholders on collaborative efforts to better support the pharmacy workforce.

A survey conducted by the Pharmacists’ Defence Association (PDA) in January revealed that over two-thirds of frontline pharmacists had not received protected learning time during contracted hours or financial compensation from their employer for training related to Pharmacy First.

Regarding future service expansions, 97% of respondents agreed that protected learning time or paid training should be mandatory to support pharmacists and staff in delivering additional pathways and conditions.

Additionally, three-quarters (75%) of surveyed pharmacists felt that the pharmacies they work in were not adequately staffed to safely deliver Pharmacy First and other NHS contractual services.

Locum pharmacists expressed challenges in completing extensive training without compensation for their time or lost earnings, while part-time pharmacists reported feeling stressed due to time pressures associated with training.

More For You

NICE approves AstraZeneca’s twice-a-day tablet ‘capivasertib’ for advanced breast cancer

HR-positive, HER2-negative advanced breast cancer is currently incurable, and treatment aims to slow progression and prolong life

Gettyimages

NICE approves twice-a-day tablet for advanced breast cancer

Every year, thousands of people with hormone receptor (HR)-positive HER2-negative breast cancer could benefit from a new twice-a-day tablet, now set to be funded immediately through the Cancer Drugs Fund.

The National Institute for Health and Care Excellence (NICE) has approved the use of capivasertib (also known as Truqap), in combination with fulvestrant, as an option for around 1,100 adults with HR-positive HER2-negative breast cancer that has certain genetic mutations and has spread.

Keep ReadingShow less
ABPI and government fast-track VPAG scheme review to address high medicine payment rates

The 2025 VPAG payment rate for newer medicines has been set at 22.9 per cent.

Photo credit: gettyimages

Review of 2024 VPAG scheme to be completed by June

The Association of the British Pharmaceutical Industry (ABPI) and the government have agreed to bring forward a planned review of the 2024 Voluntary Scheme for Branded Medicines Pricing, Access, and Growth (VPAG), originally scheduled for autumn 2025.

The review is expected to be completed in June 2025, aligning with the anticipated release of the government’s 10-year NHS Plan and the Life Sciences Sector Plan as part of the broader industry strategy this summer.

Keep ReadingShow less
AAH upgrades ordering portal, making procurement easier for pharmacies

AAH Cascade compares prices and availability across suppliers

AAH Warehouse

AAH upgrades ordering portal to improve product visibility

Leading pharmaceutical wholesaler AAH Pharmaceuticals Ltd has introduced new digital functionalities to AAH Cascade, its independently managed ordering portal, making procurement easier and more cost-effective for pharmacies.

AAH Cascade compares product prices and availability across multiple suppliers, eliminating the need for manual searches.

Keep ReadingShow less
Majority of Brits neglect consistent skincare routine,  survey finds

On average, Brits go to bed without washing their face twice a week.

Photo credit: gettyimages

Skincare: One in five Brits go to bed without washing their face daily, survey finds

Nearly two-thirds of Brits (60 per cent) neglect a consistent skincare routine,with almost one in five going to bed without washing their face daily, according to a new survey by consumer health company Kenvue.

The UK-wide survey of 2,000 people revealed that one-third of respondents (34 per cent) spend five minutes or less on their daily skincare routine. On average, Brits go to bed without washing their face twice a week.

Keep ReadingShow less
Risk of pharmacy closures remains despite record funding uplift

Community pharmacy sector remains in a fragile position as the funding gap is still significant, says CCA.

gettyimages

Pharmacy closures still a risk as funding deal fails to cover costs – warns CCA

The community pharmacy sector has secured the largest funding uplift across the NHS, yet concerns remain that it may not be enough to prevent further closures and service reductions.

Following a six-week consultation with Community Pharmacy England (CPE), the government has approved a £3.073 billion funding package for 2025/26, supplemented by an additional £215 million to support Pharmacy First and other Primary Care Recovery Plan services.

Keep ReadingShow less